Search results for "IMPAIRMENT"

showing 10 items of 434 documents

A cross-sectional and longitudinal study on the protective effect of bilingualism against dementia using brain atrophy and cognitive measures.

2020

Abstract Background Evidence from previous studies suggests that bilingualism contributes to cognitive reserve because bilinguals manifest the first symptoms of Alzheimer’s disease (AD) up to 5 years later than monolinguals. Other cross-sectional studies demonstrate that bilinguals show greater amounts of brain atrophy and hypometabolism than monolinguals, despite sharing the same diagnosis and suffering from the same symptoms. However, these studies may be biased by possible pre-existing between-group differences. Methods In this study, we used global parenchymal measures of atrophy and cognitive tests to investigate the protective effect of bilingualism against dementia cross-sectionally …

Malemedicine.medical_specialtyLongitudinal studyBrain atrophyRegion-based morphometryNeurologyBilingualismCognitive NeuroscienceCognitive reserveMultilingualismAudiology050105 experimental psychologylcsh:RC346-429lcsh:RC321-57103 medical and health sciences0302 clinical medicineAtrophymedicineHumansDementia0501 psychology and cognitive sciencesLongitudinal StudiesCognitive declinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrylcsh:Neurology. Diseases of the nervous systemAgedCognitive reserveBilingüismebusiness.industryResearch05 social sciencesBrainMild cognitive impairmentCognitionMiddle AgedAlzheimer's diseasemedicine.diseaseCognitive testCross-Sectional StudiesMalaltia d'AlzheimerNeurologyDementiaFemaleNeurology (clinical)AtrophybusinessAlzheimer’s disease030217 neurology & neurosurgery
researchProduct

Cognitive impairment: classification by 1H magnetic resonance spectroscopy.

2004

1H magnetic resonance spectroscopy (MRS) allows accurate and non-invasive in vivo metabolic study, and is a useful tool for the diagnosis of different forms of dementias. Cognitive impairment pathologies have been almost exclusively studied with MRS by comparison with healthy without a global comparison amongst Alzheimer disease (AD), vascular dementia, mild cognitive impairment (MCI) and major depression patients with cognitive impairment. Whereas decrease of N-acetylaspartate (NAA) and increase myo-Inositol (mI) at different brain locations by 1H MRS are common features of AD, Choline (Cho) alterations have been inconclusive. In our study, 64 patients with cognitive impairment were evalua…

Malemedicine.medical_specialtyMagnetic Resonance Spectroscopychemistry.chemical_compoundPosterior cingulate gyrusInternal medicinemental disordersmedicineCholineDementiaHumansProspective StudiesVascular dementiaCognitive impairmentDepression (differential diagnoses)Agedbusiness.industryMental DisordersMiddle Agedmedicine.diseasenervous systemNeurologychemistryCardiologyFemaleNeurology (clinical)Alzheimer's diseaseProtonsbusinessCognition DisordersArea under the roc curveNeuroscienceEuropean journal of neurology
researchProduct

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

2007

We evaluated the relationship between motor and neuropsychological deficits in subjects affected by amnestic Mild Cognitive Impairment (aMCI) and early Alzheimer’s Disease (AD). Kinematics of goal-directed movement of aMCI and AD subjects were compared to those of age-matched control subjects. AD showed a slowing down of motor performance compared to aMCI and controls. No relationships were found between motor and cognitive performances in both AD and aMCI. Our results suggest that the different motor behaviour between AD and aMCI cannot be related to memory deficits, probably reflecting the initial degeneration of parietal-frontal circuits for movement planning. The onset of motor dysfunct…

Malemedicine.medical_specialtyMild Cognitive ImpairmentMotor dysfunctionneuropsychologyNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAudiologyNeuropsychological TestsMotor behaviourSeverity of Illness Indexbehavioral disciplines and activitiesAlzheimer Diseasemental disordersmedicineReaction TimeHumansBiomechanicsClinical NoteAlzheimer’s DiseaseCognitive impairmentalzheimer's disease mild cognitive impairment kinematicsAgedDemographypointingMovement DisordersNeuropsychologyCognitionGeneral MedicineControl subjectsBiomechanical PhenomenaSeverity of Illness Index; Humans; Alzheimer Disease; Aged; Mental Recall; Cognition Disorders; Demography; Movement Disorders; Neuropsychological Tests; Amnesia; Biomechanics; Female; Male; Reaction TimeNeuropsychology and Physiological PsychologyNeurologykinematicsMental RecallSettore MED/26 - NeurologiaFemaleNeurology (clinical)AmnesiaPsychologyCognition DisordersNeuroscienceMovement planningRC321-571Behavioural Neurology
researchProduct

Predictors of progression from mild cognitive impairment to Alzheimer disease.

2007

Objective: To determine the occurrence of neuropsychiatric symptomatology and the relation to future development of Alzheimer disease (AD) in persons with and without mild cognitive impairment (MCI). Method: We followed 185 persons with no cognitive impairment and 47 with MCI (amnestic and multidomain), ages 75 to 95, from the population-based Kungsholmen Project, Stockholm, Sweden, for 3 years. Three types of neuropsychiatric symptoms were assessed at baseline: mood-related depressive symptoms, motivation-related depressive symptoms, and anxiety-related symptomatology. AD at 3-year follow-up was diagnosed according to Diagnostic and Statistical Manual for Mental Disorders-III-R criteria. R…

Malemedicine.medical_specialtyMild Cognitive ImpairmentPopulationNeuropsychological Testsbehavioral disciplines and activitiesDysphoriaCohort StudiesAlzheimer DiseasePredictive Value of TestsRisk FactorsInternal medicinemental disordersmedicinePrevalenceHumanseducationSuicidal ideationAgedAged 80 and overeducation.field_of_studyDepressive DisorderMood Disordersmedicine.diseaseAlzheimer's disease EpidemiologyComorbidityAnxiety DisordersMoodMood disordersDisease ProgressionAnxietySettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomAlzheimer's diseasePsychologyCognition DisordersClinical psychologyNeurology
researchProduct

Factors associated with mild cognitive impairment in a population-based cohort

2017

Il lavoro non prevede abstract

Malemedicine.medical_specialtyMultivariate analysisNeuropsychological Tests030204 cardiovascular system & hematologyMMSECDTSettore MED/13 - Endocrinologia03 medical and health sciencesPopulation based cohortBMI0302 clinical medicineRisk FactorsInternal medicineInternal MedicinemedicineHumansCognitive DysfunctionLongitudinal StudiesSettore MED/49 - Scienze Tecniche Dietetiche ApplicateCognitive impairmentAgedAged 80 and overbusiness.industryMild cognitive impairmentRegression analysisMiddle AgedCholesterolItalyAnkle-brachial indexCardiovascular DiseasesMultivariate AnalysisABCD studyPhysical therapyRegression AnalysisFemalebusiness030217 neurology & neurosurgery
researchProduct

Auditory event-related potentials in subcortical vascular cognitive impairment and in Alzheimer's disease.

2006

Few studies exist on ERPs and patients with subcortical vascular cognitive impairment (SVCI). This latter is a quite homogeneous subtype of vascular dementia whose cognitive profile is quite different from that of Alzheimer disease (AD).The present study aims at comparing the ERPs profile both in patients with SVCI and in patients with AD.ERPs and psychometric tests were collected from 39 healthy elderly controls, 51 patients with SVCI and 43 patients with AD. Subjects mentally count high pitched target tones that were randomly intermixed with low pitched frequent tones. We measured ERPs latencies (N1, P2, N2 and P3), and interpeak latencies (N1-P3, N1-P2, N1-N2).Grand averaged potentials i…

Malemedicine.medical_specialtyNeurologyAuditory eventDiseaseNeuropsychological TestsDiagnosis DifferentialAlzheimer DiseasemedicineDementiaHumansCognitive impairmentVascular dementiavascular cognitive impairmentBiological PsychiatryAgedBrainCognitionmedicine.diseasePsychiatry and Mental healthCerebrovascular DisordersNeurologybehavior and behavior mechanismsEvoked Potentials AuditorySettore MED/26 - NeurologiaFemaleNeurology (clinical)Alzheimer's diseasePsychologyCognition DisordersNeuroscienceERPdementiaJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment

2012

Neuropsychiatric symptoms (NPS) are common clinical features of Parkinson's disease (PD). However, NPS profiles in PD subjects with mild cognitive impairment (MCI) have scarcely been investigated. We aimed to describe the NPS profiles of non-demented PD subjects with and without MCI. A total of 410 non-demented PD subjects were included. Of these, 164 were cognitively normal PD subjects (PD-cn), 142 PD had amnestic MCI (PD-aMCI), and 104 had PD with non-amnestic MCI (PD-naMCI). NPS were evaluated in accordance with the Neuropsychiatric Inventory (NPI). PD-aMCI subjects revealed the highest NPS burden, followed by PD-naMCI and then PD-cn. Overall, the most common NPS in PD-MCI were in order:…

Malemedicine.medical_specialtyNeurologyParkinson's diseaseNeuropsychological TestsIrritabilitySeverity of Illness Indexbehavioral disciplines and activitiesCognitionInternal medicinemental disordersSeverity of illnessmedicineHumansCognitive DysfunctionApathyParkinson’s disease Cognitive impairment Neuropsychiatric symptoms EpidemiologyBiological PsychiatryDepression (differential diagnoses)AgedSleep disordertechnology industry and agricultureParkinson DiseaseMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyPhysical therapyAnxietyFemaleSettore MED/26 - NeurologiaAmnesiaNeurology (clinical)medicine.symptomPsychology
researchProduct

Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: underlying mechanisms

2015

Background: There are no specific treatments for the neurological alterations of cirrhotic patients with minimal hepatic encephalopathy (MHE). Rats with MHE due to portacaval shunt (PCS) show impaired spatial learning. The underlying mechanisms remain unknown. The aims of this work were to assess: (a) whether PCS rats show neuroinflammation in hippocampus, (b) whether treatment with sildenafil reduces neuroinflammation and restores spatial learning in PCS rats, and (c) analyze the underlying mechanisms. Methods: Neuroinflammation was assessed by determining inflammatory markers by Western blot. Phosphorylation of MAP-kinase p38 was assessed by immunohistochemistry. Membrane expression of GA…

Malemedicine.medical_specialtyNeurologySildenafilVasodilator AgentsInterleukin-1betaImmunologyHippocampusInflammationPortacaval shuntHippocampusp38 Mitogen-Activated Protein KinasesSildenafil Citratechemistry.chemical_compoundCellular and Molecular NeuroscienceReceptors GABANeuroinflammationmedicineAnimalsRats WistarMaze LearningHepatic encephalopathyNeuroinflammationHepatic encephalopathyInflammationMicrogliaPortacaval Shunt SurgicalTumor Necrosis Factor-alphabusiness.industryResearchGeneral NeuroscienceMacrophage Activationmedicine.diseasehumanitiesSildenafil treatmentRatscGMPmedicine.anatomical_structureCognitive impairmentReceptors Glutamatechemistrynervous systemNeurologyHepatic EncephalopathyMicrogliamedicine.symptombusinesshuman activitiesNeuroscience
researchProduct

Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease

2011

<i>Background/Aims:</i> The frequency of mild cognitive impairment (MCI) in Parkinson’s disease (PD) ranges from 19 to 40%, and this is probably due to methodological differences between the studies. The aim of this study was to evaluate the frequency and profile of MCI in a large sample of nondemented PD subjects and neurologically healthy subjects (NHS). <i>Methods:</i> A total of 872 subjects (582 controls and 290 PD) were included. The association between MCI and PD was tested, using logistic regression models; odds ratios (OR) with 95% confidence intervals (CI) were calculated. <i>Results:</i> Fifty-three percent of PD subjects and 45% NHS met the cr…

Malemedicine.medical_specialtyParkinson's diseaseNeuropsychological TestsLogistic regressionInternal medicineEpidemiologyPrevalencemedicineHumansCognitive DysfunctionParkinson’s disease Cognitive impairment EpidemiologyCognitive impairmentAgedRetrospective StudiesHealthy subjectsParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseConfidence intervalLarge sampleLogistic ModelsNeurologyPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)PsychologyNeurodegenerative Diseases
researchProduct

Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

2012

Little attention has been paid to cortical integrity in patients with minimal hepatic encephalopathy (MHE), although cognitive functions affected in early stages of liver disease are mainly allocated in different neocortical structures. Here we used cortical surface-based analysis techniques to investigate if patterns of cortical thinning accompany the mildest form of HE. To aim this goal, cortical thickness obtained from high-resolution 31 magnetic resonance imaging (MRI) was measured in patients with no MHE (NMHE), MHE, and healthy controls. Further correlation analyses were performed to examine whether scores in the critical flicker frequency (CFF) test, and blood ammonia levels accounte…

Malemedicine.medical_specialtyPathologyCognitive NeuroscienceMinimal hepatic encephalopathyPrecuneusFlicker fusion thresholdNeuropsychological TestsCortical thicknessLiver diseaseInternal medicineImage Interpretation Computer-AssistedmedicineHumansHepatic encephalopathyTemporal cortexCerebral Cortexmedicine.diagnostic_testMagnetic resonance imagingCognitionMiddle Agedmedicine.diseaseEarly diagnosisMagnetic Resonance ImagingCalcarine sulcusmedicine.anatomical_structureEarly DiagnosisCognitive impairmentNeurologyHepatic cirrhosisHepatic EncephalopathyCardiologyFemalePsychologyCognition Disordershuman activities
researchProduct